HOOKIPA Pharma Inc. (HOOK) PT Lowered to $48 at RBC Capital
RBC Capital analyst Brian Abrahams lowered the price target on HOOKIPA Pharma Inc. (NASDAQ: HOOK) to $48.00 (from $50.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)